🌏Markets:

• SPY +3.27 0.42%(pre/m)
  
• QQQ +1.17 0.16%(pre/m)
  

🆕Economic News:

• 08:15 USA – ADP Employment Change
  
• 10:00 USA – ISM Services PMI
  
• 10:30 USA – EIA Crude Oil/Gasoline Stocks Change
  

📈 Gap Ups
Reaction to earnings/guidance:

• DIS SHOP ANET UPST GTE APPS TVTX $ COMP QLYS PGEN DT KMT LRN KTOS BKNG CRCL LLY WYNN PSX NVO CVS HONA AMGN ALAB FRPT SHAK VSH
  

Other news:

• INOD Releases the First Stage of Its AI Cyber Training Suite to Enable AI Coding Agents to Write - and Repair - Secure Code
  
• Private investors are pouring growing sums into artificial intelligence projects across the developing world : NVDA BABA
  

📉 Gap Downs
Reaction to earnings/guidance:

• SPCX UBER SEDG AMD TMDX NICE GFS FLUT WULF ZETA TDC MTCH VSAT PODD PINS CDW RRX CPNG DVA GILD EOSE EOSU
  

Other news:

• AMIX Receives U.S. Patent for Precision Neuromodulation Platform Expansion
  
• Caixin reported that Chinese mainland tax authorities have started levying personal income tax on returns from offshore insurance policies. : PUK PRU HSBA STAN
  
• Samsung and SKHY evaluate Chinese chip equipment as U.S. restrictions remain a concern\
  
• INTC UMC TSEM MRVL falls in syphaty to AMD
  
• NBIS appoints Lindsey Irvine as Chief Marketing Officer
  

‼️Additional

• India has issued Zuckerberg a three-day ultimatum over the temporary removal of Modi’s address post — India Today. META +1.5%.
  
• The Trump administration has already returned more than $100 billion collected through tariffs following the Supreme Court ruling — FT.
  
• SpaceX announced a partnership with Nvidia on AI satellites. Musk: In the future, we have decided to develop products exclusively on the NVIDIA platform. NVDA
  

🏢IPO

• ATTO – Attovia Therapeutics
  Company develops next-generation biologic drugs for immune-mediated diseases using its ATTOBODY platform, a nanobody-based technology licensed from Alamar Biosciences. Lead candidate ATTO-1310 targets IL-31 and has completed Phase 1 dosing in healthy volunteers and patients with chronic itch and atopic dermatitis. Pipeline also includes programs for atopic dermatitis and inflammatory bowel disease.
  
• Price: $17.00
  
• Shares: 17.0M
  
• Raised: $289.0M
  
• Market Cap: ~$731.5M
  LTM:
  
• Revenue: $1.35M
  
• Net Income: -$64.1M
  Key point:
  
• IPO was upsized from 12.5M to 17.0M shares and priced at the top of the previous range.
  
• Comparable public companies: ALAM , ROIV , IMVT , ARGX , APLS , TERN
  

📋 List of tickers involved:
SPY QQQ DIS SHOP ANET UPST GTE APPS TVTX COMP QLYS PGEN DT KMT LRN KTOS BKNG CRCL LLY WYNN PSX NVO CVS HONA AMGN ALAB FRPT SHAK VSH INOD NVDA BABA SPCX UBER SEDG AMD TMDX NICE GFS FLUT WULF ZETA TDC MTCH VSAT PODD PINS CDW RRX CPNG DVA GILD EOSE EOSU AMIX PUK PRU HSBA STAN SKHY INTC UMC TSEM MRVL NBIS META ATTO ALAM ROIV IMVT ARGX APLS TERN

Best regards – hi2morrow team.